Advancing Science, Changing Lives
A Platform for Precision Drug Development & Testing
About TyMe Research Labs
Research Labs is the translational drug development and preclinical manufacturing division of TyMe Institute, an integrated Cancer prevention and therapeutic discovery institute. We specialize in early-stage manufacturing, drug bioactivity screening, and collaborative oncology innovation.
Our Mission
To accelerate the development of breakthrough therapies through agile manufacturing and precision biological testing, advancing new medicines from concept to clinic.
Why Partner with Research Labs
- U.S.-based infrastructure with flexible manufacturing capacity
- Oncology and immunotherapy expertise across multiple drug classes
- Fast turnaround, transparent project scoping, and scientific collaboration
- Ideal for startups, academic translational teams, and early-stage pharma programs
Our Core Capabilities and Key Offerings
Contract Testing Services (CMO Model)
Fee-for-service testing for 3rd-party compounds. NCI-60 Cancer cell panel for comparative potency profiling.
Regulatory & IND Support
Early-stage CMC documentation. Pilot production for GLP-enabling studies.
Drug Development and Manufacturing
In silico drug design, target profiling, docking, and optimization. R&D scale synthesis of small molecules.
High-Throughput Bioactivity Screening
In vitro screening in Cancer cell lines, immune cells, and stem cell-derived. Assay platforms for cytotoxicity and more.
Formulation & Process Development
Solubility and stability screening. Drug loading and vehicle compatibility studies.